Posted by Michael Wonder on 22 Sep 2018
The FDA announces Patient Engagement Advisory Committee meeting on utilising real world data from patient-driven platforms that connect and empower patients
21 September 2018 - On 15 November 2018, the FDA’s Patient Engagement Advisory Committee will hold its second public meeting to discuss how the FDA can utilise patient-driven platforms, such as social media, digital health technology and patient registry data, to inform the regulatory evaluation of medical devices.
The number of people turning to the Internet to find and share health information continues to grow. Social media aids in the creation of virtual patient communities where patients and health care consumers can share their health experiences and seek information from one another.
These platforms are potentially rich sources of patient-generated health data, which could be used in some cases as real-world evidence to help protect public health and promote health care innovation.
